205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.75%
Revenue decline while MCHP shows 11.16% growth. Joel Greenblatt would examine competitive position erosion.
-2.70%
Cost reduction while MCHP shows 5.23% growth. Joel Greenblatt would examine competitive advantage.
-8.29%
Gross profit decline while MCHP shows 15.39% growth. Joel Greenblatt would examine competitive position.
-2.69%
Margin decline while MCHP shows 3.81% expansion. Joel Greenblatt would examine competitive position.
-6.00%
R&D reduction while MCHP shows 9.74% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3650.00%
Other expenses reduction while MCHP shows 0.00% growth. Joel Greenblatt would examine efficiency.
-21.18%
Operating expenses reduction while MCHP shows 8.93% growth. Joel Greenblatt would examine advantage.
-8.67%
Total costs reduction while MCHP shows 6.76% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
6.25%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
0.55%
EBITDA growth below 50% of MCHP's 13.77%. Michael Burry would check for structural issues.
6.68%
EBITDA margin growth exceeding 1.5x MCHP's 2.34%. David Dodd would verify competitive advantages.
0.24%
Operating income growth below 50% of MCHP's 21.94%. Michael Burry would check for structural issues.
6.36%
Operating margin growth 50-75% of MCHP's 9.69%. Martin Whitman would scrutinize operations.
125.00%
Other expenses growth while MCHP reduces costs. John Neff would investigate differences.
1.05%
Pre-tax income growth below 50% of MCHP's 20.20%. Michael Burry would check for structural issues.
7.22%
Similar pre-tax margin growth to MCHP's 8.13%. Walter Schloss would investigate industry trends.
-18.62%
Tax expense reduction while MCHP shows 1632.77% growth. Joel Greenblatt would examine advantage.
9.66%
Similar net income growth to MCHP's 9.14%. Walter Schloss would investigate industry trends.
16.35%
Net margin growth while MCHP declines. John Neff would investigate advantages.
11.27%
EPS growth exceeding 1.5x MCHP's 5.26%. David Dodd would verify competitive advantages.
8.45%
Diluted EPS growth exceeding 1.5x MCHP's 5.26%. David Dodd would verify competitive advantages.
-1.01%
Share count reduction while MCHP shows 0.44% change. Joel Greenblatt would examine strategy.
-0.59%
Both companies reducing diluted shares. Martin Whitman would check patterns.